Related Experiment Video

Updated: Aug 19, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

[Magnesium, acute myocardial infarction and reperfusion injury]

Ronald Smetana1, Konrad Wink

  • 1Medicine and Konrad Wink, University Clinic Internal Medicine IV (Vienna, Austria).

Clinical Calcium
|February 5, 2005
PubMed

Insights

Magnesium plays a crucial role in treating acute myocardial infarction (AMI) by addressing increased requirements during coronary artery disease (CAD) and preventing reperfusion injury. Intravenous magnesium administration before reperfusion may become a gold standard therapy for AMI.

Area of Science:

  • Cardiology and cardiovascular research.
  • Biochemistry and molecular mechanisms of myocardial function.

Context:

  • Coronary artery disease (CAD) and acute myocardial infarction (AMI) remain leading causes of mortality.
  • Recent advancements in diagnostics and therapeutics have improved patient outcomes.
  • Emerging research highlights the critical role of magnesium in cardiovascular health.

Purpose:

  • To investigate the physiological role of magnesium in the context of CAD and AMI.
  • To explore magnesium's potential in mitigating reperfusion injury following AMI interventions.
  • To evaluate the therapeutic implications of magnesium administration in AMI management.

Summary:

  • Systemic stress from CAD increases myocardial magnesium requirements due to its role as a cofactor in ATP-dependent metabolism.
  • Reperfusion injury in AMI, linked to calcium overload, may be prevented by magnesium's calcium channel blocking properties.
  • Intravenous magnesium administration prior to reperfusion presents a promising strategy to enhance AMI treatment efficacy.

Impact:

  • Magnesium supplementation could significantly reduce myocardial damage and improve recovery after AMI.
  • This research supports the potential integration of magnesium therapy into standard AMI treatment protocols.
  • Establishes a foundation for further clinical trials investigating magnesium's role in cardiovascular interventions.

More Related Videos

Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice08:28

Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice

Published on: January 19, 2022

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...